Kehua Bio-Engineering Q1 net profit plunges 84.8%

Shanghai Kehua Bio-Engineering (SZSE:002022) reported a significant decline in financial performance for the first quarter of 2025. The net profit attributable to shareholders decreased by 84.8% compared to the same period last year, resulting in a loss of CNY 53.26 million. Revenue also saw a decrease, dropping 12.5% to CNY 387.88 million. Operating cash flow improved, showing a 64.3% increase to negative CNY 51.29 million. Basic earnings per share also took a hit, falling 82.4% to negative CNY 0.1036. Key financial metrics such as accounts receivable, accounts receivable financing, and short-term borrowings experienced notable changes. The company attributed several changes to increases in accounts receivable to the increase of bank loans and bills receivable at the end of the period.